Trial
NCT00829608
Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Missouri-Columbia
Collaborators
—
Condition
Recurrent Respiratory Papillomatosis
Intervention
Human Papillomavirus Vaccine
Why stopped
investigator has left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-05